These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11143777)

  • 1. [Antihypertensive therapy in diabetic patients. Almost as important as controlling blood glucose].
    Ritz E; Zeier M; Schwenger V
    MMW Fortschr Med; 2000 Nov; 142(47):34-8. PubMed ID: 11143777
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of blood glucose and blood pressure control on progression of diabetic nephropathy].
    Schwarz C; Oberbauer R
    Wien Klin Wochenschr; 2000 Nov; 112(21):907-11. PubMed ID: 11144004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Normalization of blood pressure and lipids in patients with diabetes].
    Clemens A; Gallwitz B
    Med Klin (Munich); 2003 Jul; 98(7):368-76. PubMed ID: 12937902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertension therapy for type 2 diabetics].
    Bönner G
    MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
    [No Abstract]   [Full Text] [Related]  

  • 5. [Guidelines for the treatment of arterial hypertension in diabetes mellitus. The consensus recommendations of the German League for the Fight against High Blood Pressure, Inc., the German Diabetes Society and the Society for Nephrology].
    Schäfers RF; Lütkes P; Ritz E; Philipp T
    Dtsch Med Wochenschr; 1999 Nov; 124(45):1356-72. PubMed ID: 10592780
    [No Abstract]   [Full Text] [Related]  

  • 6. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.
    Chaturvedi N; Bilous R; Sjolie AK; Klein R;
    Contemp Clin Trials; 2007 Nov; 28(6):780. PubMed ID: 17643353
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
    Baumgart P
    MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects].
    Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
    Przegl Lek; 2001; 58(3):124-6. PubMed ID: 11475857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of blood glucose on the course of cerebral ischemia].
    Mast H; Seyfert S; Marx P
    Nervenarzt; 1989 May; 60(5):276-9. PubMed ID: 2739819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of arterial hypertension in women with type 2 diabetes mellitus and diabetic foot syndrome].
    Onuchin SG; Elsukova OS; Onuchina EL
    Klin Med (Mosk); 2009; 87(1):45-9. PubMed ID: 19256260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prediction, screening and treatment of renal complications of diabetes].
    Marre M; Larger E
    Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial.
    Aksnes TA; Kjeldsen SE; Rostrup M; Störset O; Hua TA; Julius S
    J Hum Hypertens; 2008 Aug; 22(8):520-7. PubMed ID: 18509347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxonidine improves glycaemic control in mildly hypertensive, overweight type 2 diabetic patients.
    Cardiovasc J Afr; 2007; 18(4):271. PubMed ID: 17940677
    [No Abstract]   [Full Text] [Related]  

  • 16. Vascular and renal benefits are additive using intensive blood pressure control and incremental glucose control in type 2 diabetic patients.
    Cardiovasc J Afr; 2008; 19(5):284-6. PubMed ID: 18997995
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood pressure control, risk factors and cardiovascular prognosis in patients with diabetes: 30 years of progress.
    Mourad JJ; Le Jeune S
    J Hypertens Suppl; 2008 Sep; 26(3):S7-13. PubMed ID: 19363847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
    Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I
    Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone shift circadian rhythm of blood pressure from non-dipper to dipper type in type 2 diabetes mellitus.
    Anan F; Masaki T; Fukunaga N; Teshima Y; Iwao T; Kaneda K; Umeno Y; Okada K; Wakasugi K; Yonemochi H; Eshima N; Saikawa T; Yoshimatsu H
    Eur J Clin Invest; 2007 Sep; 37(9):709-14. PubMed ID: 17696960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postglucagon evolution of blood glucose, a test for treatment stabilization and prognosis in diabetes mellitus].
    Tacu V; Blum M; Tudor G; Dumitriu I; Dinu A; Năstasă V; Ababei V
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(2):247-51. PubMed ID: 3187231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.